This is the first comprehensive study providing a wide range of MCIDs for the PROMIS® PF, HOOS JR, and KOOS JR in orthopaedic patients with joint ailments.
No takes yet. Share an insight, caveat, or question.
Hung et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: